Atlethe's Foot

January 21, 2015 –  On this day, the U.S. Food and Drug Administration has approved Cosentyx (secukinumab) to treat adults with moderate-to-severe plaque psoriasis.  Psoriasis is a skin condition that causes patches of skin redness and irritation. Psoriasis is an …

The new psoriasis drug Secukinumab (Cosentyx), a IL-17A-inhibiting antibody, approved by the FDA Read more »